J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2 billion
An entrance sign to the Johnson & Johnson campus displays its logo in Irvine, California, on August 28, 2019. Marcos…
Merck & Co. Inc.
Moderna Stock Rises After Oppenheimer Upgrade on Pipeline Potential
Artur Widak | Nurfoto | fake images Actions of modern jumped more than 15% on Tuesday after Oppenheimer upgraded the…